Cargando…

Novel germline mutation in lung cancer pedigrees establishes BCAR1 as a human cancer susceptibility gene: a case report

BACKGROUND: Lung cancer is the most prevalent malignancy worldwide. Most cases are sporadic and carry somatic mutations in hotspot genes. However, accumulating studies have identified several germline mutations that predispose patients to lung cancer at present. CASE DESCRIPTION: In this report, 2 s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Kuikui, Zhao, Yingchao, Zhang, Sijia, Wu, Lu, Zong, Yan, Li, Zhenyu, Li, Qianwen, Cheng, Fang, Meng, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908131/ https://www.ncbi.nlm.nih.gov/pubmed/35280415 http://dx.doi.org/10.21037/atm-21-7017

Ejemplares similares

Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion
por: Zhang, Sijia, et al.
Publicado: (2022)

An unusual ectopic thymoma clonal evolution analysis: A case report
por: Zhang, Sijia, et al.
Publicado: (2023)

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics
por: Zhang, Sijia, et al.
Publicado: (2023)

Role of BCAR4 in prostate cancer cell autophagy
por: Cai, Zhiping, et al.
Publicado: (2021)

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility
por: Liu, Mengyuan, et al.
Publicado: (2020)

Pedigree based DNA sequencing pipeline for germline genomes of cancer families
por: Försti, Asta, et al.
Publicado: (2016)

Germline breast cancer susceptibility gene mutations and breast cancer outcomes
por: Wang, Yong Alison, et al.
Publicado: (2018)

BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
por: Godinho, M F E, et al.
Publicado: (2012)

Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
por: Zhang, Sijia, et al.
Publicado: (2022)

BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance
por: Cai, Zhiping, et al.
Publicado: (2018)

Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients
por: Gong, Rui, et al.
Publicado: (2019)

The Mutationathon highlights the importance of reaching standardization in estimates of pedigree-based germline mutation rates
por: Bergeron, Lucie A, et al.
Publicado: (2022)

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
por: Godinho, M F E, et al.
Publicado: (2010)

Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion
por: Guo, Alvin Kunyao, et al.
Publicado: (2020)

BCAR3 promotes head and neck cancer growth and is associated with poor prognosis
por: Zhang, Ze, et al.
Publicado: (2021)

Long non-coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion
por: Wang, Aiyao, et al.
Publicado: (2020)

Pedigree analysis of the EGFR p.V1010M germline mutation in a family with a family history of non-small-cell lung cancer
por: Li, Na, et al.
Publicado: (2022)

The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers
por: Tu, Chao, et al.
Publicado: (2019)

Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
por: Stoltze, Ulrik, et al.
Publicado: (2018)

LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
por: Gan, Feng-Jiao, et al.
Publicado: (2021)

Novel germline ERCC5 mutations identified in a xeroderma pigmentosum complementation group G pedigree
por: Wang, Tao, et al.
Publicado: (2015)

Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation
por: Wu, Xia, et al.
Publicado: (2022)

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway
por: Dorssers, Lambert CJ, et al.
Publicado: (2005)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions across Solid Tumors
por: Nickless, Andrew, et al.
Publicado: (2022)

FLOT1 promotes gastric cancer progression and metastasis through BCAR1/ERK signaling
por: Wang, Ran, et al.
Publicado: (2023)

Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma
por: Feng, Huayi, et al.
Publicado: (2023)

Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees
por: Lin, Huan, et al.
Publicado: (2020)

Clinical and genomic features of Chinese lung cancer patients with germline mutations
por: Peng, Wenying, et al.
Publicado: (2022)

BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer
por: Zhou, Xiaoshu, et al.
Publicado: (2022)

Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2018)

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
por: Qin, Yuejuan, et al.
Publicado: (2010)

Germline EGFR mutations in lung cancer (Review)
por: Liu, Minghui, et al.
Publicado: (2023)

Correction: BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
por: Bae, Kieun, et al.
Publicado: (2020)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
por: Ma, Yi, et al.
Publicado: (2018)

LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling
por: Ouyang, Shurui, et al.
Publicado: (2017)

LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer
por: Wu, Tangwei, et al.
Publicado: (2023)

Loss of AND-34/BCAR3 expression in mice results in rupture of the adult lens
por: Near, Richard I., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_euje946r5livpeh9tlh96ngpoh